Tetraneuron

📍 Madrid, Spain, Spain🗓 Founded 2012👥 20 employees💰 Last funded Dec 2025
Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition.
6
Total investors
0
Early stage
0
Mid stage
5
Late stage
2012
Founded
Investor geography2 countries
Spain
5
United States
1
Investor activity2020–2025 · investors recorded per year
20201202122022220251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Tetraneuron?
Tetraneuron has 6 investors on record on gritt.io and 5 late-stage investors.
When did Tetraneuron last raise funding?
The most recent investment in Tetraneuron recorded on gritt.io was in December 2025.
When was Tetraneuron founded?
Tetraneuron was founded in 2012.
What industry is Tetraneuron in?
Tetraneuron operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Tetraneuron based?
Tetraneuron is headquartered in Madrid, Spain, Spain.